Hao Lin

机构：Guangzhou University of Chinese Medicine, Shandong Provincial Hospital, Shandong First Medical University · ORCID：0009-0001-3219-2401

发表论文 23 篇 · 总被引 434 次 · h-index 5

代表论文

• Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives (2024 · Journal of Hematology & Oncology · 被引 355)
• Physicochemical, Antibacterial Properties, and Compatibility of ZnO-NP/Chitosan/β-Glycerophosphate Composite Hydrogels (2022 · Journal of Microbiology and Biotechnology · 被引 25)
• Adverse effects of advanced glycation end products on embryonal development. (2008 · PubMed · 被引 15)
• The metabolic activation of pentachlorophenol to chloranil as a potent inhibitor of human and rat placental 3β-hydroxysteroid dehydrogenases (2024 · Toxicology Letters · 被引 11)
• Efficacy and Safety of Apatinib in Patients with Recurrent Glioblastoma (2023 · Drugs in R&D · 被引 7)
• Efficacy of personalized 3D-printed osteotomy guide in maximizing fibular utilization and minimizing graft length for reconstruction of large mandibular defect (2024 · Clinical Oral Investigations · 被引 5)